Human African Trypanosomiasis: First in Man Clinical Trial of a New Medicinal Product, the SCYX-7158
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
This study is aimed at assessing the tolerability and pharmacokinetic parameters of SCYX-7158
in healthy volunteers. In animal models of both acute and chronic experimental
Trypanosomiasis infections, SCYX-7158 shows highly promising efficacy.